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Abstract
Background: The peptidyl-prolyl isomerase Pin1 recently revealed itself as a new player in the
regulation of protein function by phosphorylation. Pin1 isomerizes the peptide bond of specific
phosphorylated serine or threonine residues preceding proline in several proteins involved in
various cellular events including mitosis, transcription, differentiation and DNA damage response.
Many Pin1 substrates are antigens of the phosphodependent monoclonal antibody MPM-2, which
reacts with a subset of proteins phosphorylated at the G2/M transition.
Results: As MPM-2 is not a general marker of mitotic phosphoproteins, and as most mitotic
substrates are phosphorylated more than once, we used a different phosphodependent antibody,
mAb CC-3, to identify additional mitotic phosphoproteins and eventual Pin1 substrates by
combining affinity purification, MALDI-TOF mass spectrometry and immunoblotting. Most CC-3-
reactive phosphoproteins appeared to be known or novel MPM-2 antigens and included the RNA-
binding protein p54nrb/nmt55, the spliceosomal protein SAP155, the Ki-67 antigen, MAP-1B, DNA
topoisomerases II α and β, the elongation factor hSpt5 and the largest subunit of RNA polymerase
II. The CC-3 mitotic antigens were also shown to be Pin1 targets. The fine CC-3- and MPM-2-
epitope mapping of the RNA polymerase II carboxy-terminal domain confirmed that the epitopes
were different and could be generated in vitro by distinct kinases. Finally, the post-mitotic
dephosphorylation of both CC-3 and MPM-2 antigens was prevented when cellular Pin1 activity
was blocked by the selective inhibitor juglone.
Conclusion: These observations indicate that the mitotic phosphoproteins associated with Pin1
are phosphorylated on multiple sites, suggesting combinatorial regulation of substrate recognition
and isomerization.
Background
One of the biggest challenge in cell biology and cancer
research is still to understand how cells divide and pro-
ceed to the equal partition of their genetic material in each
daughter cell. The mechanisms underlying mitosis and
cytokinesis are tightly controlled and reversible protein
phosphorylation plays a major role in this regulation [1].
Early and late mitotic events are dependent on protein
phosphorylation by multiple serine and threonine
kinases of the NIMA, Polo and Aurora families at the head
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of which sits the Cdk1/cyclin B complex [1-5]. The nature
of most protein substrates of these kinases is still
unknown so that the precise roles they play in the regula-
tion of mitosis and cytokinesis remain to be clarified.
A few monoclonal antibodies (mAbs) have been raised in
different laboratories against mitotic cell extracts and
shown to react with subsets of proteins that are phospho-
rylated upon entry into mitosis [6-9]. The most character-
ized of these antibodies, mAb MPM-2, was selected for its
preferential reactivity towards mitotic versus interphase
cells [6] and shown to react with a phospho-epitope
present on a set of proteins concentrated in the centro-
somes, the kinetochores, the mitotic spindle and the mid-
body [6,10], reinforcing the idea that the structural
rearrangements observed during mitosis are controlled by
phosphorylation events. After twenty years of continuous
use as a mitotic marker in scores of laboratories -and
insistent efforts to characterize the epitope(s) and the
kinases involved- it is now clear that many MPM-2 anti-
gens are important mitotic regulators and effectors. They
include the Cdc25 phosphatase [11], the Cdk1-inhibitory
Wee1 and Myt1 kinases [12-14], the NIMA kinase [15],
the microtubule associated-proteins MAP-1 and MAP-4
[16,17], DNA topoisomerase II α and β [18], p42mapk
[19], and the Cdc27 component of the anaphase-promot-
ing complex (APC) [20]. Phosphorylation of the MPM-2
antigenic sites is thought to be functionally important as
the MPM-2 antibody inhibits oocyte maturation upon
microinjection and neutralizes mitosis promoting factor
activity from M-phase extracts [21].
The biological relevance of MPM-2 phosphoepitopes was
further reinforced when Shen and coworkers [22] showed
that the peptidyl-prolyl isomerase (PPIase) Pin1 could
bind and regulate many mitotic phosphoproteins also rec-
ognized by MPM-2. PPIases are ubiquitous enzymes cata-
lyzing the cis-trans isomerization of the peptide bond
preceding a proline residue and are thought to be
involved in protein folding, protein assembly, protein
trafficking or in the direct regulation of protein activity
[23]. Pin1 is unique among prolyl isomerases in that it
specifically targets proline residues preceded by a phos-
phoserine (pS-P) or a phosphothreonine (pT-P) [24-26].
Pin1 is a ubiquitously expressed protein that is essential
for cell cycle progression in yeast and in mammalian cells
[27]. Furthermore, Pin1 has been shown to interact with
the essential mitotic kinase NIMA and to suppress its
mitosis-promoting activity [27]. It is now believed that
Pin1 acts as an essential mitotic regulator since, in addi-
tion to NIMA, it binds other MPM-2-reactive proteins
with important mitotic functions including Cdc25
[22,28], Myt1, Wee1, Plk1 and Cdc27 [22]. In the recent
years, it was postulated that the analysis of the phosphor-
ylated sites recognized by both Pin1 and MPM-2 might be
a good starting point for a better understanding of the
general role of phosphorylation in the mitotic processes.
These efforts, mainly orchestrated by K.P. Lu and collabo-
rators, have led to the elaboration of a novel post-phos-
phorylation regulatory mechanism, in which the
isomerase Pin1 induces conformational changes into tar-
geted proteins that have been first phosphorylated by pro-
line-directed kinases [29,30].
The regulative action of Pin1 may not be confined to
mitotic processes. Recent results have shown that DNA
damage induces an interaction between Pin1 and p53
depending on specific pS-P motifs in p53 [31-33], indicat-
ing that phosphorylation-dependent prolyl isomerization
is a signalling mechanism also operating in the genotoxic
response [34]. Interestingly, it was shown that efficient
binding of the p53 protein to Pin1 requires phosphoryla-
tion at all three sites of p53 involved in the interaction
[32,33].
Previous work from our laboratory has shown that, in
human interphase cells, Pin1 interacts with two transcrip-
tion-related proteins in a phosphorylation-dependent
manner: the hyperphosphorylated form of RNA polymer-
ase II largest subunit Rpb1 [35], and a phosphorylated
form of the transcription elongation factor hSpt5 [36].
Moreover, studies in yeast provided genetic evidence that
Ess1, the yeast homolog of Pin1, interacts with the tran-
scription machinery as most genetic suppressors of ess1
mutants encode proteins involved in transcription [37]
consistent with the earlier observation that ess1 mutants
are defective in mRNA processing [38,39]. These results
also indicate that Pin1 operates at multiple levels.
The discovery of the association of Pin1 with Rpb1 and
hSpt5 was made possible thanks to the availability of a
monoclonal antibody (mAb CC-3) selected for its strong
phospho-dependent reactivity with mitotic cells and with
nuclear speckles of interphase cells [7]. The interphase
CC-3 antigens located in the nuclear speckles were identi-
fied as Rpb1 and hSpt5 [35,36] but the numerous CC-3
mitotic antigens have not been identified yet. As CC-3
behavior was somewhat reminescent of that of MPM-2, a
comparison of both mAbs initially revealed that they
share the hyperphosphorylated form of Rpb1 as their
major interphase antigen [35]. However, their epitope on
Rpb1 appeared to be different since upon a heat shock,
MPM-2 reactivity was increased whereas that of CC-3 was
diminished, suggesting that both antibodies may discrim-
inate between distinct functional forms of RNA polymer-
ase II [35,40].
In the present work, MALDI-TOF mass spectrometry and
immunoblotting were combined to identify the major
CC-3 mitotic antigens. They included a few proteinsBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/22
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involved in transcription and/or mRNA maturation and
most of them also appeared to be known or novel MPM-
2 antigens. The fine CC-3- and MPM-2-epitope mapping
of the carboxy-terminal domain (CTD) of Rpb1 con-
firmed that the epitopes are different and can be generated
in vitro by distinct kinases. Pulldown experiments suggest
that the CC-3 mitotic antigens are also Pin1 targets.
Finally, incubation of HeLa cells with juglone, an irrevers-
ible Pin1 inhibitor [41], prevented the dephosphorylation
of both mitotic MPM-2 and CC-3 epitopes. These observa-
tions suggest that Pin1 might promote M phase exit by
stimulating the dephosphorylation rate of the mitotic reg-
ulators and/or effectors on multiple sites revealed by
mAbs CC-3 and MPM-2.
Results
MAb CC-3 is a mitotic marker
CC-3 and MPM-2 are phosphodependent mouse mono-
clonal antibodies strongly reactive with mitotic cells [6,7].
In interphase cells, the reactivity of both antibodies is con-
fined to discrete nuclear speckles and has been previously
shown to be mainly mediated by phosphoepitopes
located on the CTD of Rpb1 [35]. The immunoblot reac-
tivities of CC-3 and MPM-2 on mitotic extracts reveal that
their mitotic antigens are much more numerous and the
overall patterns are sufficiently distinct to expect that CC-
3 and MPM-2 epitopes are different [35]. In addition, the
comparison of CC-3 and MPM-2 immunofluorescence
reactivities at different stages of the cell cycle reveals subtle
differences between otherwise similar patterns. For exam-
ple, the centrosomes of interphase cells [35] as well as the
midbodies during cytokinesis (data not shown) are
labelled more intensely with MPM-2.
Since several MPM-2 antigens identified up to now play
an important role in cell division, it appeared relevant to
identify the mitotic phosphoproteins recognized by mAb
CC-3. The CC-3-antigens were affinity-purified from
mitotic extracts and separated by one-dimensional SDS-
PAGE. The major bands were submitted to in-gel tryptic
digestion and processed for MALDI-TOF mass spectrome-
try (Table 1). They were identified as the proliferation-
associated Ki-67 protein, the microtubule-associated pro-
tein MAP-1B, the spliceosomal protein SAP155 and the
RNA-binding protein p54nrb/nmt55. As suitable antibod-
ies were available, the nature of the two latter was con-
firmed by immunoblotting (Fig. 1A). NMT-5, a
polyclonal rabbit antibody raised against the middle part
of the p54nrb/nmt55 protein [42] and an antibody to
SAP155 [43] were used to confirm the presence of slower
migrating forms of both proteins in the mitotic CC-3
immunoprecipitate (Fig. 1A, lower panels). These CC-3-
reactive bands most probably represent mitosis-specific
phosphorylated forms of p54nrb/nmt55 and SAP155.
Interestingly, the former was also detectable in the MPM-
2 mitotic immunoprecipitate (Fig. 1A) and may thus rep-
resent a novel MPM-2 antigen. Recently, p54nrb/nmt55
was shown to bind to the CTD of Rpb1 [44]. To eliminate
the possibility that it merely co-purified with CC-3-reac-
tive Rpb1, p54nrb/nmt55 was immunoprecipitated from
mitotic extracts with the anti-p54nrb/nmt55 antibody and
immunoblotted. As shown on figure 1B, the p54nrb/
nmt55 band reacted with both CC-3 and MPM-2 antibod-
ies. In addition, it has been possible to generate the CC-3-
epitope by incubating recombinant p54nrb/nmt55 with a
mitotic extract and ATP (Proteau A. et al., unpublished
results).
Since the CC-3 immunoreactivity in the high Mr region is
rather complex [35], alternative methods to MALDI-TOF
mass spectrometry were used to identify other CC-3-anti-
gens. A few candidate proteins in the 170–220 kDa range
of SDS gels were already suspected because they had been
described as MPM-2 antigens (DNA topoisomerases II α
and β) or because they reacted with mAb CC-3 in inter-
phase cells (Rpb1 and hSpt5). Thus, immunoblots using
anti-DNA topoisomerase II α and β showed reactive
bands in the MPM-2 as well as in the CC-3 mitotic immu-
noprecipitates. Likewise, Rpb1 and hSpt5 also proved to
be mitotic CC-3- and MPM-2-antigens (Fig. 1A). There-
fore, it turns out that most of the CC-3 mitotic antigens
identified up to now are also MPM-2 reactive: p54nrb/
nmt55, Rpb1 and hSpt5 as novel mitotic MPM-2 antigens
and MAP-1B, Ki-67 and DNA topoisomerases II as already
known MPM-2 antigens. The spliceosomal protein
SAP155 is the sole mitotic antigen specifically recognized
by CC-3 identified to date. These results prompted us to
meticulously compare the nature of the CC-3 and MPM-2
epitopes on a common mitotic and interphase antigen,
the CTD of Rpb1.
Fine CC-3 and MPM-2 epitope mapping on the CTD of 
Rpb1
To map the MPM-2 and CC-3 epitopes of Rpb1, recom-
binant GST-tagged fragments of the CTD of human Rpb1
were used (Fig. 2A). The N-CTD construct encodes the
amino-terminal 26 repeats of the CTD, eighteen of which
being identical to the consensus heptad YSPTSPS. The C-
CTD construct corresponds to the carboxy-terminal 26
repeats and includes only three heptads conform to the
consensus sequence. When the fragments were incubated
with a mitotic extract and ATP, CC-3-reactivity was
strongly induced on the C-CTD peptide but less intensely
on the N-CTD (Fig. 2B). These results are consistent with
a previous observation that starfish cdc2 kinase could gen-
erate a strong CC-3 signal on the C-teminal part of the
CTD [45]. On the other hand, the MPM-2 epitope was
weakly generated using the mitotic extract but a strong sig-
nal was obtained using the Cdk9/cyclinT1 kinase (Fig.
2B). Here, the reactivity appeared stronger on the N-CTD.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/22
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In both cases however, the epitopes seemed somewhat
repetitive as CC-3 and MPM-2 reacted with both frag-
ments incubated with the mitotic kinases or with Cdk9,
respectively (Fig. 2B). As expected, neither the unphos-
phorylated GST-CTDs (arrows in Fig. 2B), nor the phos-
phorylated GST alone (data not shown) were reactive with
the antibodies.
The fine epitope characterization of the antibodies was
carried out by probing immobilized CTD peptides with
CC-3 and MPM-2 (Fig. 3A). These peptides contained four
YSPTSPS heptad repeats phosphorylated at serines 2 and/
or 5 since the CTD repeats are thought to be predomi-
nantly phosphorylated at these positions [46-48]. In
agreement with previous observations [49], CC-3 was
shown to recognize the CTD repeats phosphorylated on
Serine-2 and the reactivity was decreased by 50% when
both Serine-2 and Serine-5 were phosphorylated (Fig.
3A,3B). On the other hand, the strongest MPM-2 signal
was obtained when both Serine-2 and Serine-5 were phos-
phorylated. Surprisingly, at the lowest peptide concentra-
tion, MPM-2 reacted only with the unphosphorylated
CTD form and the reactivity remained constant at higher
peptide concentrations. These results, independently cor-
roborated in Dr Buratowski's laboratory (personal com-
munication), were unexpected since MPM-2 does not
react with unphosphorylated recombinant N-CTD and C-
CTD (Fig. 2B). In all likelihood, the short CTD peptides
used in this assay do not perfectly imitate the structural
complexity of an integral CTD. One possible explanation
is that MPM-2 does not recognize the phosphoserine but
a proline conformation affected by the phosphorylation
of a serine residue. It has to be mentionned that a
preincubation of the immobilized CTD peptides with
recombinant Pin1 protein decreased the reactivity of both
antibodies with the phosphorylated peptides but not that
of MPM-2 with the unphosphorylated peptide (data not
shown).
CC-3 antigens are also targets for the cis/trans peptidyl-
prolyl isomerase Pin1
The preceding results support the idea that CC-3 and
MPM-2 are two different mitotic markers with distinct
substrate specificities to phosphorylated serines or thre-
onines. The peptidyl-prolyl isomerase Pin1 specifically
isomerizes the pS/pT-P peptide bond. It is composed of an
amino-terminal WW domain responsible for the binding
to pS/pT-P sites on substrates and a unique peptidyl-pro-
lyl isomerase domain (PPIase) that specifically cis/trans
isomerizes pS/pT-P bonds [26]. Pin1 binds to a subset of
mitotic phosphoproteins, many of which are also recog-
nized by MPM-2 [22]. A pulldown experiment was carried
out to verify whether Pin1 could also bind to CC-3 mitotic
antigens (Fig. 4A). Recombinant Pin1 was immobilized
on a resin and further incubated with mitotic HeLa cell
Confirmation of the identity of some CC-3 antigens by  immunoblotting Figure 1
Confirmation of the identity of some CC-3 antigens 
by immunoblotting. (A) Mitotic cell extracts were immu-
noprecipitated with either CC-3 and MPM-2 and immunob-
lotted with different antibodies against proteins suspected to 
be CC-3 antigens. Lysates from asynchronous (AH) and 
mitotic (MH) HeLa cells were also electrophoresed and 
immunoblotted. Both CC-3 and MPM-2 immunoprecipitates 
contained hyperphosphorylated forms of Rpb1 and hSpt5, 
the α and β isoforms of DNA topoisomerase II and p54nrb/
nmt55. However, only CC-3 is able to precipitate mitotic 
SAP155. (B) Mitotic cell extracts were immunoprecipitated 
with antibody NMT-5, a rabbit polyclonal raised against 
p54nrb/nmt55 and immunoblotted with MPM-2, CC-3 and 
NMT-1, a monoclonal to p54nrb/nmt55. Note that a still uni-
dentified mitotic antigen migrating more slowly than p54nrb/
nmt55 in the mitotic HeLa cell sample is reactive with CC-3 
in this region of the gel (asterisk). IP: immunoprecipitating 
mAb, IB: immunoblotting mAb.
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homogenates prior to washes and elution. Western blots
clearly showed that both groups of mitotic antigens were
depleted from the extract by incubation with recombinant
Pin1. To confirm that Pin1 binding was mediated by its
WW domain, a Pin1 recombinant protein mutated in this
domain (W34A) was shown to be less effective than the
wild type protein and a mutant of the PPIase domain
(C113A) in pulling down mitotic CC-3 and MPM-2 anti-
gens (Fig. 4A). However, traces of Pin1 substrates were
still visible in the W34A eluted fraction despite a final 60
mM imidazole wash. This binding could be due to non-
specific binding activity of the Nickel column although an
irrelevant protein (Pbp5), loaded on Nickel beads as a
control His-tagged fusion protein, retained less mitotic
proteins than the W34A mutant (Fig. 4A, right panel).
Actually, the main band retained by the His-tagged Pbp5-
Nickel column was p54nrb/nmt55, whose sequence con-
tains a stretch of histidine residues in its N-terminal
extremity [50]. Alternatively, the presence of Pin1 sub-
strates in the W34A eluted fraction could be either due to
residual binding activity of the mutated WW domain or to
the intact catalytic domain of the construct as it was
shown that the PPiase domain can also bind, although at
a lower affinity, to the same pS/pT-P-containing substrates
[30]. A Coomassie blue stained gel of the eluted fractions
showed that an equivalent amount of Pin1, mutant pro-
teins and Pbp5 were used in each pulldown experiment
(Fig. 4B).
To verify whether the interaction between Pin1 and the
CC-3- and MPM-2-reactive mitotic phosphoproteins was
direct and driven by the WW domain, immunopurified
CC-3 and MPM-2 antigens were subjected to a blot over-
lay experiment using Pin1 and the WW mutant as probes
(Fig. 4C). The specificity of the Pin1 overlay was con-
firmed by the absence of reactivity of the molecular weight
marker bands (Fig. 4C, lane M). In addition, a more
robust and complex reactivity was noticed, as expected, on
a mitotic extract compared to an interphase extract when
equivalent protein amounts were loaded (Fig. 4C, lanes 1
and 2). The strong binding of Pin1 to mitotic CC-3 and
MPM-2 immunoprecipitated antigens suggests that Pin1
association with these phosphoproteins is direct (Fig. 4C,
lanes 5 and 6). Both CC-3 and MPM-2 interphase immu-
noprecipitates (lanes 3 and 4) were also processed and the
result confirmed that Rpb1 and at least one other inter-
phase protein, most probably hSpt5, interact directly with
Pin1 (Fig. 1 and [36]). The WW mutant W34A showed a
marked reduction of binding in the blot overlay experi-
ment (Fig. 4C, middle panel), supporting the view that
CC-3 mitotic antigens are, like MPM-2 antigens, direct tar-
gets of Pin1 and that this interaction is driven by the WW
domain. Finally, it has to be noticed that the SAP155 pro-
tein, which appeared to be a CC-3-positive and a MPM-2-
negative antigen (Fig. 1A) was pulled down by Pin1 as
revealed by Western blot (Fig. 4D), suggesting that the
MPM-2-immunoreactivity may not be a prerequisite for
Pin1 binding. In addition, DNA topoisomerase II α,
shown to be a common antigen to both antibodies (Fig.
1), was also specifically pulled down by Pin1 (Fig. 4D).
CC-3 and MPM-2 antigens are not dephosphorylated after 
mitosis in the presence of juglone, a Pin1 specific inhibitor
Juglone is a naphtoquinone which specifically inhibits the
members of the parvulin PPIase family [41]. We asked
whether Pin1 inhibition by juglone might affect the phos-
phorylation level of CC-3 and MPM-2 antigens upon
mitosis exit. Mitotic HeLa cells were harvested after noco-
dazole treatment and incubated for a 5-hour period in the
presence or absence of juglone. In juglone-free medium,
the cells were observed to adhere to the plastic dish
whereas in juglone-containing medium, the cells stayed
rounded and unattached (data not shown). Western blots
of the resulting samples are shown in figure 5. As
expected, the immunoreactivity of both antibodies
decreased when mitotic cells were chased into G1 in the
absence of juglone (Fig. 5: compare lanes 1 to lanes 2). In
the juglone-treated cells however, the phosphorylation
level of most mitotic CC-3 and MPM-2 antigens remained
unaltered (Fig. 5, lanes 3 and 4). Moreover, a Western blot
using antibody POL3/3, a non phosphodependent mAb
against Rpb1, showed that the hyperphosphorylated form
of Rpb1 was the only detectable species after a 5-hour
incubation in the presence of the inhibitor. Thus, juglone
might favor CC-3 and MPM-2 phosphoantigen accumula-
tion at the exit of mitosis, possibly by making substrates
less susceptible to phosphatase activity in the absence of
Pin1.
Table 1: Novel CC-3 mitotic antigens identified by MALDI-TOF-MS and ProFound research engine
Identified CC-3 
mitotic antigens
Accession 
number
Theoretical 
molecular weight
Number of 
matched peptides
Measured 
peptides
Min. sequence 
coverage (%)
Estimated 
Z score
Probability
Ki-67 long form 14746822 360.9 kDa 37 86 11 2.04 1.0e+000
Ki-67 short form 14746812 321.5 kDa 19 32 4 1.59 1.0e+000
MAP-1B, isoform 1 5174525 271.8 kDa 22 86 11 1.13 1.0e+000
SAP155 14042921 146.5 kDa 15 56 11 0.78 0.99e-000
P54nrb/nmt55 13124797 54.2 kDa 8 31 15 1.96 1.0e+000BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/22
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The CC-3 and MPM-2 epitopes of recombinant Rpb1 are  generated by different kinases Figure 2
The CC-3 and MPM-2 epitopes of recombinant Rpb1 
are generated by different kinases. (A) Schematic repre-
sentation of the N- and C- moieties of the CTD of Rpb1 
fused to GST tags for in vitro phosphorylation experiments. 
The N-CTD comprised the first 26 repeats of the consensus 
YSPTSPS and the C-CTD comprised the more degenerated 
last 26 repeats. (B) N-CTD and C-CTD recombinant pro-
teins were phosphorylated with a mitotic extract or with 
Cdk9/cyclin T1 and subjected to SDS-PAGE and immunob-
lotting with CC-3 and MPM-2. Arrows indicate the position 
of unphosphorylated N-CTD and C-CTD controls, revealed 
by Ponceau red staining prior to immunostaining. Mitotic 
kinases strongly enhanced CC-3-reactivity in the C-CTD 
fragment whereas Cdk9/cyclin T1 generated more efficiently 
the MPM-2 epitope, especially in the N-CTD fusion protein. 
N: N-CTD, C: C-CTD.
Fine mapping of CC-3 and MPM-2 epitopes on Rpb1 consen- sus heptad repeats Figure 3
Fine mapping of CC-3 and MPM-2 epitopes on Rpb1 
consensus heptad repeats. (A) Biotinylated CTD pep-
tides were immobilized on a streptavidin-coated ELISA plate 
at three different concentrations and incubated with MPM-2 
and CC-3. These peptides contained four YSPTSPS repeats, 
phosphorylated either on the serine residues at position 2 
(YSPTSPS), at position 5 (YSPTSPS) or at both positions 
(YSPTSPS). An unphosphorylated peptide was used as a con-
trol (YSPTSPS). CC-3 was mainly reactive with peptides 
phosphorylated on serine 2 of the consensus repeat whereas 
MPM-2 reacts preferentially with the peptide phosphorylated 
on both serines 2 and 5. Surprisingly, MPM-2 also reacted 
with the unphosphorylated peptide in a concentration inde-
pendent manner (see text). (B) Histogram of the CC-3 and 
MPM-2 reactivities shown in (A).BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/22
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The direct interaction of Pin1 with CC-3 and MPM-2 mitotic antigens involves its WW domain Figure 4
The direct interaction of Pin1 with CC-3 and MPM-2 mitotic antigens involves its WW domain. (A) Mitotic HeLa 
cell homogenates were incubated with histidine-binding resins saturated with different his-tagged proteins. WT: wild type Pin1; 
W34A: a Pin1 protein mutated in the WW domain; C113A: a Pin1 protein mutated in the PPIase domain; Pbp5: an irrelevant 
protein used as a control. Aliquots from the initial lysate (+), the flowthrough (-), the washes (w1 to w3) and the eluted frac-
tions (E) were subjected to SDS-PAGE and immunoblotting. The Pin1 WT and C113A resins retained more MPM-2 and CC-3 
mitotic antigens than the WW mutant W34A and the Pbp5 control resins. (B) Coomassie blue staining of a 15% acrylamide gel 
of the fractions eluted from the different resins in (A) showing that the initial amounts of the bound his-tagged proteins were 
similar. (C) Blot overlay experiments using either the wild type or the WW mutant Pin1 protein as a probe showing the direct 
interaction of wild type Pin1 with CC-3 interphase (lane 3) and mitotic (lane 5) antigens as well as with MPM-2 interphase (lane 
4) and mitotic (lane 6) antigens, obtained by immunoprecipitation. Lanes 1 and 2 correspond to total homogenates prepared 
from asynchronous and mitotic HeLa cells respectively. Pin1 did not bind to the Mr markers (lane M) nor to the major bands 
of the total homogenates (lanes 1 and 2) visualized by Coomassie blue staining (right panel) but did bind strongly to the CC-3 
and MPM-2 antigens. No binding was observed when the W34A mutant protein was used as a probe (middle panel). (D) Pin1 
specifically binds to SAP155 and DNA topoisomerase II α. Same experiment as that described in (A) except that the eluted 
fractions from the his-tagged Pin1 and Pbp5 resins were immunoblotted with antibodies to DNA topoisomerase II α and 
SAP155.
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Discussion
Many observations strongly support the idea that mAb
CC-3 reacts with a phosphodependent epitope different
from that recognized by MPM-2. First, in immunofluores-
cence studies of HeLa cells, MPM-2 labelled additional
structures when compared to CC-3. Second, the Western
blot patterns of both antibodies showed major differences
[35]. Third, some proteins may react exclusively with
either CC-3 or MPM-2 as illustrated by the CC-3-exclusive
SAP155 antigen. Fourth, a heat shock treatment of HeLa
cells increased MPM-2 immunoreactivity of Rpb1 whereas
that of CC-3 was decreased [35,40]. Finally, the experi-
ments using the CTD recombinant fragments and pep-
tides of Rpb1 showed that MPM-2 and CC-3 epitopes can
be differentially generated in vitro by distinct kinases.
Altogether, these observations indicate that the CC-3 and
MPM-2 phosphoepitopes are different and that a single
mitotic phosphoprotein may be phosphorylated on sev-
eral sites by different kinases, suggesting a combinatorial
regulation of the mitotic events. Multisite phosphoryla-
tion of proteins is a common mechanism to increase the
regulatory potential of proteins [51] and was envisaged a
few years ago for the regulation of cell division by Stuke-
nberg and coworkers [52] after they have systematically
undertaken the identification of mitotic phosphoproteins
using a screening procedure based on either electro-
phoretic mobility shifts or MPM-2-epitope recognition.
Their study revealed that MPM-2 recognition was not a
hallmark of all mitotic phosphoproteins and that no com-
mon motifs existed among the substrates that are phos-
phorylated during mitosis. On the other hand, most of the
proteins they have identified contained several S-P or T-P
groupings and displayed multiple phosphorylated forms
[52]. This observation could explain the variety of immu-
noreactivities noticed with both CC-3 and MPM-2 and the
association of their antigens with Pin1 as seen in the over-
lay experiments. More recently, Stukenberg and Kirschner
[53] found that a Pin1-catalyzed conformational change -
monitored among other assays by MPM-2 differential
reactivity- was located in such a "SP-rich" region on
Cdc25. Whether Pin1 catalyzes similar conformational
changes on other mitotic (or interphase) substrates
remain to be demonstrated but mAb CC-3 certainly con-
stitutes an additional probe to reach this objective.
A striking feature of the major CC-3 antigens identified in
our study is that many of them localize to the nucleus in
interphase cells and are associated with transcriptional
and/or pre-mRNA processing events. This finding is con-
sistent with one conclusion of Stukenberg and coworkers
[52] that is, a large percentage of the proteins
phosphorylated during mitosis are transcriptional and
translational regulators. Recently, the splicing factor
SAP155 was shown to be highly phosphorylated in mitot-
ically arrested COS-1 cells and HeLa cells compared to
asynchronous cells [54]. The phosphorylated sites lie in a
TP-rich domain that mediates binding to NIPP1, a splic-
ing factor that functions also as a PP1 phosphatase regula-
tor. The use of the Cdk inhibitor roscovitine and the in
vitro phosphorylation of SAP155 with Cdk1 strongly sup-
port the idea that Cdk1/cyclin B is the major SAP155
mitotic kinase. The relevance of NIPP1-SAP155 interac-
tion may contribute to the mitotic silencing of splicing
[54]. These results support the present finding that
SAP155 is mitotically phosphorylated in mitosis on the
mAb CC-3-epitope and that Cdk1 could be the major CC-
3 mitotic kinase (see below). Among the CC-3-reactive
proteins that we have identified, the splicing and tran-
scription-associated protein p54nrb/nmt55 and the
human transcription elongation factor hSpt5 appeared to
be novel MPM-2 antigens. The former possibly corre-
sponds to a previously described MPM-2-reactive p55 pro-
tein shown to be threonine phosphorylated upon entry in
mitosis [55]. The p54nrb/nmt55 protein contains one
putative Cdk1 consensus site (QNHTPRK) in its most N-
terminal part and several T-P pairs in a proline-rich
Juglone, a Pin1 inhibitor, prevents exit from mitosis and  dephosphorylation of CC-3 and MPM-2 mitotic antigens Figure 5
Juglone, a Pin1 inhibitor, prevents exit from mitosis 
and dephosphorylation of CC-3 and MPM-2 mitotic 
antigens. Mitotic HeLa cells were withdrawn from nocoda-
zole-containing medium and incubated for 5 hours in the 
absence (lane 2) or in the presence of juglone at 10 (lane 3) 
or 20 µg/ml (lane 4). The cells were then solubilized in sam-
ple buffer and processed for immunoblotting with CC-3, 
MPM-2 and POL3/3, a monoclonal antibody recognizing both 
hypo- and hyperphosphorylated forms of Rpb1. Lane 1 rep-
resents a sample of the cells removed before the 5-hour 
incubation and thus corresponds to t = 0. The juglone treat-
ment prevented the dephosphorylation of the MPM-2 and 
CC-3 antigens after removal of nocodazole. The POL3/3 
immunoblot revealed that Rpb1 became hyperphosphor-
ylated after incubation with juglone (lanes 3 and 4) whereas 
the 5-hour chase in the absence of juglone (lane 2) allowed 
the cells to recover the usual 1:1 ratio of hypo- to hyper-
phosphorylated forms of Rpb1.
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domain in its carboxy terminus [50]. This protein con-
tains two RNA recognition motifs within a 320-aa stretch
also found in the splicing factor PSF. Its expression was
shown to be down regulated in a subset of breast tumors
[42]. The mouse homolog of p54nrb/nmt55, NonO, was
independently isolated as a DNA binding transcription
factor [56], able to enhance the association of many DNA-
binding proteins to their targets [57]. Interestingly, the
p54nrb/nmt55 and PSF proteins of HeLa cells have
recently been shown to specifically bind the CTD of Rpb1
and it has been suggested that these proteins could pro-
vide a direct link between transcription and pre-mRNA
processing [44]. This property could be the cause of the
purification of p54nrb/nmt55 by CC-3-affinity since the
CTD, as shown on figure 1, contains several CC-3
epitopes. However, we think that p54nrb/nmt55 is a bona
fide CC-3 antigen and that it did not merely co-purify as a
Rpb1 partner because it was shown to be CC-3-reactive in
Western blots when immunoprecipitated from mitotic
extracts with the anti-p54nrb/nmt55 antibody. In addition,
we have recently been able to generate the CC-3-epitope
on a recombinant p54nrb/nmt55 protein in vitro using
ATP and a mitotic extract as a source of kinases (Proteau
A., unpublished results).
The repetitive nature of the CTD, which harbors an
impressive series of phosphorylable S-P or T-P pairs,
makes Rpb1 one of the more complex CC-3 and MPM-2
antigens. The results described in figure 2 revealed a
stronger CC-3 affinity for the GST-CTDs phosphorylated
by a mitotic extract than by Cdk9/cyclinT1, as opposed to
MPM-2 reactivity. Maybe most importantly, the genera-
tion of the CC-3 epitope by the mitotic extract was
stronger on the C-CTD, which possesses only three con-
sensus YSPTSPS repeats. As starfish Cdk1 kinase could
generate a strong CC-3 signal on the C-teminal part of the
CTD in vitro [45], this observation could mean that Cdk1
is the major kinase of our mitotic extract involved in phos-
phorylation of the CC-3 epitope. This segment of the CTD
contains mostly heptads diverging from the consensus at
position 7 and it was shown by Zhang and Corden [58]
that the best susbtrate for Cdk1 was a CTD peptide with a
lysine at this position (YSPTSPK). It has previously been
shown that TFIIH also increased CC-3 immunoreactivity
at the C-terminal half of the CTD in vitro [45] and Cdk7,
a component of TFIIH, preferentially phosphorylates syn-
thetic heptapeptides containing a lysine at position 7 [59].
Altogether, these observations suggest that the CC-3
epitope can be generated by a phosphorylated serine at
position 2 of the consensus repeat, as demonstrated by
the ELISA reactivity of the (YSPTSPS)4 peptides and in a
previous study [49], but the affinity of the antibody is
most probably enhanced by the natural context of the non
canonical repeats of the C-CTD and presumably, by a sim-
ilarly permissive environment in the mitotic antigens. In
line with this suggestion, it has to be noticed that mAb
H5, also directed to Serine-2 of the CTD [49], revealed a
single reactive band corresponding to Rpb1 when blotted
on mitotic cell extracts (not shown). Therefore, in spite of
the identical specificity of H5 and CC-3 towards the Ser-
ine-2 of the CTD, CC-3 clearly recognizes a different motif
surrounding the pS-P bond since it reacts with many more
mitotic phosphoproteins.
The Cdk9-induced MPM-2 epitope appeared stronger in
the highly conserved N-terminal part of the CTD in agree-
ment with a previous report showing that the Cdk9 kinase
complex preferentially phosphorylates this portion of the
CTD [60]. In addition to demonstrating the different
nature of both epitopes, these observations support the
view that whichever kinases are involved, MPM-2 and CC-
3 could react with functionally distinct isoforms of hyper-
phosphorylated Rpb1. Remarkably, the loss of the CC-3
epitope and the concurrent increase of MPM-2 reactivity
noticed after a heat shock [35,40], could mean that the
bulk of phosphorylated serine residues shift from the C-
terminal half of the CTD to the N-terminal part under
these conditions. Work is under progress to verify if the
stress-induced hyperphosphorylation of the CTD contrib-
utes to the appearance of the MPM-2 epitope. It has to be
kept in mind that such a net increase in the phosphoryla-
tion level of Rpb1 could result from the stress-induced
activation of kinases [61] and/or inactivation of a CTD
phosphatase [62]. According to the ELISA results showing
a stronger MPM-2 and a weaker CC-3 reactivity when the
CTD peptides are phosphorylated on both serines 2 and 5,
it could also be that the heat shock treatment increases the
phosphorylation level of Rpb1 on both serines 2 and 5,
providing an alternative explanation to the fact that MPM-
2 immunoreactivity is increased by this treatment and that
of CC-3 is decreased. Whether the heat shock-induced
alterations of the CTD phosphorylation contribute to the
modifications of gene expression characteristic of the heat
shock response remains to be explored.
As CC-3 and MPM-2 antigens were shown to be targets of
the peptidyl-prolyl isomerase Pin1, it was of interest to
examine their dephosphorylation at the exit of mitosis. It
has indeed been shown that Pin1 can alter the dephos-
phorylation rate of some of its binding partners [63-65].
When nocodazole-arrested mitotic cells were chased into
G1 in the presence of juglone, a Pin1 inhibitor [41], we
observed that most CC-3 and MPM-2 antigens remained
in the phosphorylation state contrary to the situation in
juglone-free medium. In addition, the cells treated with
the inhibitor remained rounded and did not attach to the
culture dish. Because juglone potentially interacts at other
levels [66], these results should be interpreted with cau-
tion, but they are consistent with the recent suggestion
that Pin1 could regulate the activity of phosphoproteinsBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/22
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distributed at different mitotic structures by controlling
the accessibility of pS/pT-P motifs to phosphatases [67].
Further experiments using more specific Pin1 inhibitors
such as those recently discovered by Uchida and collabo-
rators [68] will help to resolve this issue.
Conclusions
We provided evidence that another monoclonal antibody,
CC-3, recognizes a different epitope borne by a subset of
mitotic phosphoproteins which, for the most part, are
also MPM-2 antigens and Pin1-reactive, suggesting the
existence of a combinatorial regulative mechanism. The
availability of different phosphorylation-state-specific
antibodies to mitotic antigens may thus be crucial to elu-
cidate the functional impact of multisite phosphorylation
of regulators and effectors on cell division.
Methods
Cell cultures and synchronization
HeLa cells (American Type Culture Collection) were cul-
tured in Iscove's Modified Dulbecco's Medium (Gibco)
supplemented with 10% FBS (Medicorp) at 37°C in 5%
CO2. Mitotic HeLa cells were obtained by incubating the
cells with nocodazole (Sigma-Aldrich) at a final concen-
tration of 0.08 µg/ml for 16 hours. In some experiments,
mitotic HeLa cells were harvested, washed twice with PBS
and incubated in medium supplemented or not with
juglone (Sigma-Aldrich) for 5 hours at 37°C. Stock
solutions of juglone were freshly prepared in 0.1N NaOH
and used at a final concentration of 10 or 20 µg/ml.
Antibodies
MAb CC-3 (IgG2a) was obtained after immunization of a
Balb/C mouse with pharyngeal regions isolated from 72-
hour chick embryos in a search for developmental mark-
ers [7,69]. The mouse monoclonal antibody MPM-2
(IgG1) was purchased from Upstate Biotechnology. MAb
POL3/3 (IgG1) recognizes Rpb1 in a conserved region
located outside the CTD and was kindly provided by E. K.
F. Bautz [70]. NMT-5 (rabbit polyclonal antibody) and
mouse monoclonal NMT-1 were raised against the splic-
ing cofactor p54nrb/nmt55 and were kindly provided by A.
M. Traish [42]. The anti-SAP155 is a rabbit polyclonal
antibody kindly provided by R. Reed [43]. The anti-hSpt5
monoclonal rat antibody raised against a C-terminal frag-
ment of the human Spt5 protein was a gift from H. Handa
[71]. The anti-DNA topoisomerase II α (8D2) and anti-
DNA topoisomerase II β (5A7) were kindly provided by
M. Tanaka [72]. The anti-Pin1 polyclonal antibody was
raised by immunizing a rabbit with purified full-lenght
His-tagged recombinant Pin1 protein [35].
Sample preparation and immunoprecipitation
For whole cell extracts, interphase and mitotic HeLa cells
were directly solubilized in sample buffer (63 mM Tris pH
6.8, 2.3% SDS, 5% β-mercaptoethanol, 10% glycerol) and
boiled for 6 minutes. For immunoprecipitation, mitotic
or interphase cells were homogenized at 4°C in IP buffer
(50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM EDTA,
0.2% NaF, 0.8% SDS, 1 mM EDTA, 1X protease inhibitor
cocktail (Roche Diagnostics) and 40 nM microcystin). The
lysates were sheared with a 25G needle several times and
boiled for 5 minutes. To neutralize the SDS and to allow
antigen-antibody interactions, one volume of Triton
buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM
EDTA, 0.2% NaF, 4% Triton X-100, 1 mM EDTA, 1X pro-
tease inhibitor cocktail and 40 nM microcystin) was
added to the lysates and cleared by centrifugation at
16000 g for 5 minutes. Lysates were incubated for 90 min-
utes at room temperature with the primary antibodies first
coated on goat anti-mouse IgG (whole molecule)-agarose
(Sigma-Aldrich). The beads were washed in the same
buffer followed by antigen solubilization in electrophore-
sis sample buffer.
Immunoblots
Samples were resolved by 7% or 10% SDS-PAGE gels and
transfered to nitrocellulose membranes. The blots were
blocked with 1% blocking reagent (Roche Diagnostics)
diluted in Tris-buffered saline (TBS-T) (10 mM Tris pH
7.65, 150 NaCl and 0.05% Tween-20) for 60 minutes at
37°C and probed overnight with the primary antibodies
at 4°C. Peroxydase-conjugated anti-mouse or anti-rabbit
secondary antibodies (Jackson ImmunoResearch Labora-
tories) were used for chemiluminescence detection
(Roche Diagnostics). The molecular mass markers used
were: myosin heavy chain (205 kDa), β-galactosidase
(116 kDa), phosphorylase b (97 kDa), bovine serum
albumin (66 kDa), ovalbumin (45 kDa) and carbonic
anhydrase (29 kDa).
MALDI-TOF-MS analysis
The purification of CC-3 mitotic antigens was carried out
by immunoprecipitation of mitotic cell extracts solubi-
lized in the IP buffer as described above. The purified anti-
gens were separated on a 9% SDS-PAGE gel, Coomassie
blue stained and relatively enriched protein bands were
excised and subjected to in-gel trypsin digestion as
described [73]. Mass spectrometry analysis and protein
purification were performed at the Centre de protéomique
de l'est du Québec (Dr G. G. Poirier, dir.). An aliquot (1
µl) of the peptide extract was mixed with 1 µl saturated
solution of α-cyano-4-hydroxycinnamic acid matrix (10
mg/ml) prepared in TFA (Trifluoroacetic acid 0.1%, Ace-
tonitrile 50%) and submitted to MALDI-TOF mass spec-
trometry using a Voyager DE PRO mass spectrometer
(Applied Biosystems). Molecular masses of the tryptic
peptide profiles were used to search by peptide finger-
printing the National Center for Biotechnology Informa-
tion (NCBI) database using the ProFound softwareBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/22
Page 11 of 13
(page number not for citation purposes)
(ProteoMetrix). Defined search parameters were as fol-
lows: monoisotopic mass tolerance 0.20 Da, 1 missed cut
allowed, cystein as S-carbamidomethyl-derivative and
oxidation of methionine allowed. The reported results
were selected on the basis of restriction to species Homo
sapiens.
In vitro phosphorylation
The Cdk9/cyclin T1 complex has been kindly provided by
Dr O. Bensaude and was prepared from baculovirus-
infected Sf9 cells as described [74]. For the mitotic extract,
nocodazole-treated cells were prepared as above and
homogenized in 3–5 pellet volumes of extraction buffer
(50 mM Tris pH 7.4, 250 mM NaCl, 1 mM EDTA, 50 nM
NaF, 1 mM DTT, 0.1% Triton X-100, 1X protease inhibitor
cocktail and 40 nM microcystin). The lysate was solubi-
lized with a 25G needle and spun for 30 minutes at 16
000 g. The GST-N-CTD and the GST-C-CTD fusion pro-
teins were produced from a pGEX-3X (Pharmacia) con-
struction kindly provided by Dr M. Vigneron [45] and
purified on glutathione-Sepharose (Sigma-Aldrich). The
GST-CTD recombinant proteins were phosphorylated in
vitro with the mitotic extract for 60 minutes at 30°C in a
final assay volume of 25 µl containing 50 mM Tris pH 7.5,
10 mM MgCl2, 1 mM EGTA, 2 mM DTT, 40 mM β-glycer-
ophosphate, 20 mM ρ-nitrophenylphosphate, 0.1 mM
sodium vanadate, 20 nM microcystin, 0.7 mM ATP, 5 µl
of mitotic extract and 0.2 µg of N-CTD or C-CTD.
Alternatively, the constructs were phosphorylated by
Cdk9/cyclin T1 in glycerophosphate buffer (20 mM
sodium glycerophosphate pH 7.3, 5 mM MgCl2, 1 mM
EDTA, 1 mM DTT, 10% glycerol) with 1 mM ATP for 60
minutes at 30°C. The phosphorylated peptides were puri-
fied on glutathione Sepharose resin, eluted with sample
buffer and subjected to SDS-PAGE.
CC-3 and MPM-2 reactivity of synthesized CTD peptides
For analysis of CC-3 and MPM-2 reactivity of the CTD,
biotinylated CTD peptides containing four consensus
repeats (YSPTSPS) phosphorylated in all repeats at the
indicated serines were used (a kind gift of Dr S.
Buratowski [75]). Peptides were coupled to streptavidin-
coated 96-well plates (Pierce) and processed for ELISA
according to the instructions of the manufacturer except
that TBS-T was used as the washing buffer and that 1%
blocking reagent (Roche Diagnostics) in TBT-T was used
to block the plate and to dilute the CC-3 and MPM-2 anti-
bodies. Peroxydase-conjugated anti-mouse IgG secondary
antibody (Jackson ImmunoResearch Laboratories) was
used at 1/1000. The colorimetric reaction was developed
using ABTS tablets (Roche Diagnostics) and the resulting
absorbances were recorded at 405 nm with a Vmax kinetic
microplated reader from Molecular Devices.
Pin1 pulldown experiments
His-tagged Pin1 recombinant protein was cloned and
purified as described [35]. His-tagged Pin1 mutants W34A
and C113A were kindly provided by Dr O. Bensaude.
Equivalent amounts of wild-type and mutant Pin1 pro-
teins and of an irrelevant his-tagged protein (Pbp5) used
as a control were loaded onto distinct histidine-binding
columns (Novagen) and incubated for 1 hour at 4°C with
mitotic HeLa cell lysates prepared in fresh CHAPS buffer
(25 mM Tris pH 7.5, 150 mM NaCl, 0.5% CHAPS, 0.2%
NaF, 2X protease inhibitor cocktail without EDTA and 40
nM microcystin) and clarified at 16 000 g for 30 minutes
at 4°C. The resins were then washed three times with
CHAPS buffer containing increasing imidazole concentra-
tions (10 mM, 35 mM and 60 mM). Bound fractions were
eluted with sample buffer 2X and heated for 5 minutes at
95°C. Volumes corresponding to the same cellular equiv-
alents were subjected to Western blots.
Pin1 blot overlay
Different samples were separated on a 10% SDS-PAGE gel
and transfered on nitrocellulose. The membrane-bound
proteins were renatured overnight at 4°C in Blotto (5%
lyophilized skim milk dissolved in PBS (pH 7.1) contain-
ing 0.2% Tween-20, 1 mM DTT and 1 mM PMSF) and
incubated for 2 hours at the same temperature with 1.3
µg/ml of wild-type or W34A mutant Pin1 proteins. The
membranes were washed 3 × 15 minutes in Blotto with-
out DTT and PMSF, incubated with the anti-Pin1 anti-
body (1/10 000 dilution) for 1 hour at room temperature
and processed for chemiluminescence as described above.
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